Table 1: The
key clinicopathological characteristics of the patients.
|
Characteristic |
Number
of patients (%) |
|
Age (years) |
|
|
<49
years |
46(59) |
|
≥49
years |
32(41) |
|
|
|
|
Site of tumor |
|
|
Rt. |
43(55) |
|
Lt.
|
35(45) |
|
|
|
|
Histological type |
|
|
Invasive
ductal carcinoma (IDC) |
69(89) |
|
Mucinous carcinoma |
3
(4) |
|
Invasive lobular carcinoma (ILC) |
3(4) |
|
Papillary carcinoma |
1(1) |
|
Secretory carcinoma |
1(1) |
|
Cribriform carcinoma |
1(1) |
|
|
|
|
Histological Grades |
|
|
G1 |
13(17) |
|
G2 |
48(61) |
|
G3 |
17(22) |
|
|
|
|
Stage |
|
|
I |
6(8) |
|
IIA |
23(29) |
|
IIB |
13(17) |
|
III |
1(1) |
|
IIIA |
18(23) |
|
IIIB |
1(1) |
|
IV |
16(21) |
|
|
|
|
Primary tumor: |
|
|
T1 |
6(8) |
|
T2 |
44(56) |
|
T3 |
28(36) |
|
|
|
|
Lymph node involvement |
|
|
No |
35(45) |
|
Yes |
43(55) |
|
|
|
|
Distance metastasis |
|
|
No |
62(79) |
|
Yes |
16(21) |
|
|
|
|
Chemotherapy |
|
|
No |
7(9) |
|
Yes |
71(91) |
|
|
|
|
Radiotherapy |
|
|
No |
26(33) |
|
Yes |
52(67) |
|
|
|
|
Hormone replacement therapy |
|
|
No |
29(37) |
|
Yes |
49(63) |
|
|
|
|
Recurrence |
|
|
No |
70(90) |
|
Yes |
6(8) |
|
|
|
|
Estrogen |
|
|
No |
32(41) |
|
Yes |
45(58) |
|
|
|
|
Progesterone |
|
|
No |
31(40) |
|
Yes |
46(59) |
|
|
|
|
Her-2 |
|
|
No |
59(76) |
|
Yes |
18(23) |
|
|
|
|
Multifocality |
|
|
No |
70(90) |
|
Yes |
8(10) |
|
Free surgical margin |
|
|
No |
16(21) |
|
Yes |
20(26) |
|
|
|
|
Vascular invasion |
|
|
No |
58(74) |
|
Yes |
20(26) |
|
|
|
|
Positive family history |
|
|
No |
74(95) |
|
yes |
4(5) |